Currently out of the existing stock ratings of Rajesh Kumar, 14 are a BUY (51.85%), 8 are a HOLD (29.63%), 5 are a SELL (18.52%).

Rajesh Kumar

Work Performance Price Targets & Ratings Chart

Analyst Rajesh Kumar, currently employed at HSBC, carries an average stock price target met ratio of 50.93% that have a potential upside of 11.7% achieved within 120 days.

Rajesh Kumar’s has documented 54 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PFE, Pfizer at 06-Jul-2026.

Wall Street Analyst Rajesh Kumar

Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 7/14/2023. The price target of $560 was fulfilled within 55 days with a profit of $119.26 (27.06%) receiving and performance score of 4.92.

Average potential price target upside

of $29.11 (29.95%) on MRK (MERCK MPANY).
of $28.58 (20.93%) on ABBV (ABBVIE).
of $20.86 (11.12%) on IQV (IQVIA HOLDINGS).

DHR Danaher ABBV AbbVie BIIB Biogen BMY Bristol-Myers Squibb Company IQV IQVIA Holdings LLY Eli Lilly and Company MRK Merck mpany PFE Pfizer TMO Thermo Fisher Scientific

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Subbu Nambi (GUGGENHEIM)